Blog

Regulatory intelligence for people doing the actual work

Practical guides on medical device registration and international expansion.

Regulatory updates · October 2026

Each change checked against the authority's own instrument. Every dated change is also on the regulatory change tracker.

💴
Reimbursement · Asia-Pacific

Medical Device Reimbursement in Japan, Korea, Taiwan and Australia: What the Number Actually Means

Registration isn't payment. How each market pays for a device, who decides, who is paid, and six ways a reimbursement figure gets misread.

November 13, 2026  ·  11 min read
🪖
Market Access · Startups

Military Use of Unapproved Medical Devices: Which Countries Allow It, and Who Holds the Key

Eight countries, including France, Switzerland and Australia, have a military route for devices that are not yet approved. In every one, the military holds it, not the manufacturer.

November 2, 2026  ·  9 min read
🩺
Reimbursement · Startups

Medicare Coverage for Breakthrough Devices in 2026: RAPID, TCET and the End of the NTAP Shortcut

RAPID is still a proposal, TCET is closed to new devices, and the NTAP shortcut is gone. Who RAPID is for, and what to do now.

November 2, 2026  ·  8 min read
🔍
How-to · Investors

Six Regulatory Checks Before You Invest in a Device Company

The regulatory line in a device deck is public record. Approvals and dates, the local license holder, the predicate chain, class by market, the order of markets, and who is already registered.

October 28, 2026  ·  5 min read
📈
Strategy · Startups

Your Regulatory Plan Is a Fundraising Document

Investors read the regulatory plan as the revenue plan. Six things it should show, from the route in each market to how far the money goes.

October 28, 2026  ·  5 min read
🇦🇺
Regulatory · Software and AI

Australia narrows its clinical decision support software exemption on 1 November 2026

From 1 November 2026, Australian clinical decision support software stays off the ARTG only if it passes five tests, including showing its logic and not making the decision itself. What changed, which software now needs ARTG…

October 20, 2026  ·  10 min read
🗓️
Regulatory update · Issue 1

What moved in medical device regulation, October 2026: deadlines, AI rules and easier entry

November deadlines in the EU, China and Australia; new rules for AI and software devices in Australia, Indonesia and the EU; easier entry in India, Korea, Vietnam and Taiwan; the EU's first device HTA picks; higher US fees.…

October 20, 2026  ·  18 min read
🤖
Analysis · AI and software devices

AI medical devices in Japan, Great Britain and the EU: where each regulator stands in October 2026

Japan has a draft for generative-AI devices, Great Britain has 44 government commitments, and the EU moved the AI Act to 2028 for devices. What differs, what carries across, and what an AI device company should file first.…

October 20, 2026  ·  14 min read
🌏
Regulatory · Southeast Asia

Four changes this autumn that reorder a Southeast Asia entry plan

Thailand now recognizes Malaysian device approvals in law, which completes a loop of reliance routes between Malaysia, Singapore and Thailand. With Malaysia's expiring classification letters, Indonesia's local validation for…

October 20, 2026  ·  12 min read
🌎
Regulation · Americas

The Americas, August to October 2026: what changed for device makers, and the dates to plan around

What changed for medical device makers in Canada, Mexico, Colombia, Chile and Argentina from August to October 2026, with a dated calendar of the deadlines that follow. Most of the new work falls on your local importer or…

October 20, 2026  ·  12 min read
🔎
Regulatory analysis

Five regulatory headlines from this autumn that do not apply to medical devices

Singapore's partnerships, Kenya's GMP reliance guideline, India's IVD documents, Mexico's ANVISA pathway and the UK's 14-day Phase 1 review were all read as device news. What each instrument actually says, the device route…

October 20, 2026  ·  11 min read
🇪🇺
Regulatory analysis

The EU picked its first two devices for a joint clinical assessment. Here is what that means for a high-risk device company.

The EU selected two transcatheter mitral valves for its first device joint clinical assessments. Which devices can be selected, the timeline after CE marking, what you must submit, the one lever a startup has, and where…

October 20, 2026  ·  10 min read
🇮🇳
Regulatory update · India

India's 2026 IVD changes: new guidance, the same rules

What CDSCO published on in-vitro diagnostics in 2026, which documents are drafts, when comments close, and why the August EU waiver does not reach a new IVD. Checked against the Medical Devices Rules and each document.

October 20, 2026  ·  9 min read
🇹🇼
Change alert · Taiwan

Running a device trial in Taiwan: what changed in October 2026

From October 2026 Taiwan files and records device clinical trials on one platform: what changed in the application instructions, what a running trial must now do, and why a startup should look again at Taiwan for an early study.

October 20, 2026  ·  9 min read

Start Here

Market Strategy

Practical Guides

Not sure where to start?

Tell us where you are, and we'll point you to the right first step.

Most companies come to us with one of these four questions. Each one is a conversation, not a form.

See how this looks for your own products and markets

Talk to us about your expansion plans, and see yourself in our solution.